Pre-operative predeposit autologous donation in children presenting for elective surgery: a review

Area of Science:

• Pediatric Hematology
• Transfusion Medicine
• Patient Blood Management

Background:

• Allogeneic blood transfusions in children carry risks including pathogen transmission and alloimmunization.
• Alloimmunization can complicate future transfusions, organ transplants, and pregnancies.
• Predeposit autologous blood donation (PAD) offers a potential alternative to mitigate these risks.

Purpose of the Study:

• To review the existing literature on predeposit autologous blood donation (PAD) in pediatric practice.
• To analyze the risk-benefit profile of adopting PAD in children.
• To evaluate PAD's role in pediatric blood conservation programs.

Main Methods:

• Literature review of studies on predeposit autologous blood donation in pediatric populations.
• Analysis of reported complications and benefits associated with PAD.
• Risk-benefit assessment of PAD implementation in pediatric care.

Main Results:

• PAD in children is associated with a decrease in lifetime complications linked to allogeneic blood.
• Key benefits include reduced risk of pathogen transmission and alloimmunization.
• The study explores the balance between the advantages and potential drawbacks of PAD.

Conclusions:

• Predeposit autologous blood donation (PAD) presents significant long-term advantages for pediatric patients.
• PAD should be considered a valuable component of pediatric blood conservation strategies.
• Further evaluation of PAD's risk-benefit is warranted for widespread adoption in pediatric practice.